Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Laryngeal Diseases 1Breast Neoplasms 1

Interventions

Cisplatin 5pembrolizumab 4Surveys and Questionnaires 2Radiotherapy 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Fluorouracil 2Docetaxel 2Cetuximab 2niraparib 1monalizumab 1linrodostat 1durvalumab 1dostarlimab 1Tablets 1Surgical Flaps 1Radiotherapy, Intensity-Modulated 1Radiation 1Nivolumab 1LY2940680 1Interviews as Topic 1Combined Modality Therapy 1Chemical Fractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Diseases × Chemical Fractionation × 1 year × Clear all
NCT03656133 2026-02-20

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
55 enrolled 10 charts
Head & Neck

Laryngeal Diseases, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡